-
全球生物粘合剂市场报告(2021-2028年)
Bioadhesives are defined as naturally occurring polymeric materials, which possess adhesive characteristics
and can adhere to biological surfaces. This substance includes glues created by using biological intermediates
such as starch, cellulose, or gelatin. With the growing popularity of bioadhesives, owing to their environmentfriendly
nature, they are preferred over synthetic adhesives. These adhesives find their application in several
end-use industries such as wood, packaging & paper, construction, and medical industries.
-
在美国,中医药发展机遇与挑战并存
截至2018年1月1日,美国已经有47个州及哥伦比亚特区通过了针灸法,确保了中医针灸在这些州的合法使用和发展。2018年10月,时任美国总统特朗普签署HR6法案,同意针灸作为一种证据充分、行之有效的阿片药物替代疗法,这使针灸首次在美国联邦法律上得到承认。
-
全球人工角膜和角膜植入物市场报告(2021-2028年)
Corneal implant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from
individuals who have donated their eyes for the benefit of others. The report provides market dynamics and
trends related to the global artificial cornea and corneal implants market. The study estimates revenue
generated from sales of artificial cornea; however, it excludes artificial cornea and corneal implants service
revenue. Furthermore, the report excludes revenue generated from post-sale services of artificial cornea and
corneal implants.
-
原料药自主生产 印度胜算几何
近年来,印度政府正在按照“自力更生的印度”(Atmanirbhar Bharat)行动计划,采取多项举措,以期实现医疗保健行业自主自立。去年,该国政府宣布了一项幅度从5%~20%不等的生产相关性激励措施(PLIs),以促进印度国内对重要原料药的生产。此外,印度政府计划与印度相关邦联合建立三个大型原料药工业园,预计投入1430亿卢比,生产用于急救药物的化学产品,减少从中国进口,并希望将药品进口关税从10%提高到25%,以促进本土化生产。上述措施的目的是,确保未来印度民众获得的药品供应不会遭遇中断困境,提供负担得起的医疗保健服务。不过,想要实现这些目标,印度面临巨大挑战。